|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.080 CAD | +0.98% |
|
0.00% | +14.07% |
| 06-15 | BioRem Inc.'s Equity Buyback announced on June 11, 2025, has expired. | CI |
| 05-14 | BioRem Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 49.95M 35.33M 30.9M 28.5M 26.32M 3.37B 50.79M 341M 134M 1.66B 133M 130M 5.71B | P/E 2026 * |
10.3x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 49.95M 35.33M 30.9M 28.5M 26.32M 3.37B 50.79M 341M 134M 1.66B 133M 130M 5.71B | EV / Sales 2026 * |
1.05x | EV / Sales 2027 * | - |
| Free-Float |
97.53% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.98% | ||
| Current month | -1.28% | ||
| 1 month | +0.33% | ||
| 3 months | +26.49% | ||
| 6 months | +26.23% | ||
| Current year | +14.07% |
| 1 week | 2.98 |  | 3.1 |
| 1 month | 2.98 | | 3.15 |
| Current year | 2.26 | | 3.57 |
| 1 year | 1.87 | | 3.57 |
| 3 years | 0.81 | | 3.57 |
| 5 years | 0.42 | | 3.57 |
| 10 years | 0.22 | | 3.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
Derek Webb
CEO | Chief Executive Officer | - | 2014-12-16 |
Douglas Newman
DFI | Director of Finance/CFO | - | - |
Mark Smit
CTO | Chief Tech/Sci/R&D Officer | - | 2016-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Derek Webb
BRD | Director/Board Member | - | 2014-12-16 |
Alex Gill
BRD | Director/Board Member | - | 2020-06-21 |
William White
CHM | Chairman | 74 | 2020-06-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-09-23 | Tax | Company | 4,600 | 0.0285% | ||
| 25-09-23 | Tax | Company | 20,000 | 0.1241% | ||
| 25-09-23 | Tax | Company | 20,000 | 0.1241% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | 0.00% | +29.96% | +227.66% | 35.33M | |
| +2.23% | -1.53% | - | - | 18.35B | |
| +0.81% | +0.17% | +26.47% | +42.28% | 10.34B | |
| -0.82% | +1.80% | +172.77% | +525.50% | 4.88B | |
| -0.69% | +1.89% | +73.07% | +298.62% | 4.53B | |
| -2.16% | -1.67% | +160.09% | +163.49% | 1.93B | |
| +0.33% | -5.73% | - | - | 1.34B | |
| +3.26% | -6.94% | +176.67% | +169.15% | 1.05B | |
| +0.08% | -4.84% | -20.98% | -11.09% | 919M | |
| -5.21% | -15.47% | +52.68% | +35.83% | 880M | |
| Average | -0.05% | -2.58% | +83.84% | +181.43% | 4.43B | |
| Weighted average by Cap. | +0.91% | -1.06% | +80.22% | +198.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.5M 33.59M 29.39M 27.1M 25.03M 3.2B 48.3M 324M 127M 1.58B 126M 123M 5.43B | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | $3.080 | +0.98% | 23,833 |
| 26-07-09 | $3.050 | +0.66% | 2,700 |
| 26-07-08 | $3.030 | +0.66% | 3,065 |
| 26-07-07 | $3.010 | -2.27% | 43,063 |
| 26-07-06 | $3.080 | 0.00% | 5,038 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.080CAD
Average target price
3.500CAD
Spread / Average Target
+13.64%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BRM Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
